Contenu disponible en anglais seulement.
Bulletin de la Bourse
Sernova Corp. (SVA) inscrit à la Bourse de Toronto
31 mai 2022
| Issuer: | Sernova Corp. (the "Company") |
| Security: | Common shares ("Shares") |
| Symbol: | SVA |
| Number of securities issued and outstanding: | 275,624,662 Shares |
| Number of securities reserved for issuance: | 87,502,296 Shares |
| Trading currency: | CDN$ |
| Listing and posted for trading date: | June 2, 2022 (at the opening) |
| Listing category: | Industrial, Non-Exempt Issuer |
| Other market(s): | The Shares have been listed on TSX Venture Exchange ("TSXV") in their current form since September 20, 2006 under the symbol "SVA". The Shares will be delisted from TSXV on June 2, 2022 upon commencement of trading on Toronto Stock Exchange. |
| Temporary market maker: | RBC Capital Markets |
| Security ownership registration: | Certificated Issue |
| Investor relations: | Corey Davis LifeSci Advisors LLC +1 (212) 915-2577 cdavis@lifesciadvisors.com -OR- Christopher Barnes VP, Investor Relations +1 (519) 902-7923 christopher.barnes@sernova.com |
| Incorporation: | Canada Business Corporations Act |
| Fiscal year end: | October 31 |
| Nature of business: | The Company is a clinical-stage regenerative medicine cell therapeutics company focused on development and commercialization of its proprietary technologies, including Cell Pouch implantable device technologies and immune-protected therapeutic cells. |
| Transfer agent and registrar: | TSX Trust Company at its principal offices in Vancouver and Toronto. |
| Dividends: | None anticipated in the foreseeable future |
| Sponsorship: | Not applicable |
| TSX contact: | Anne Child, Director, TSX Listings |